-+ 0.00%
-+ 0.00%
-+ 0.00%

Northstar Ventures leads GBP 1.3 million funding round for Magnitude Biosciences

PUBT·09/15/2026 10:54:01
Listen to the news
Northstar Ventures leads GBP 1.3 million funding round for Magnitude Biosciences
  • Magnitude Biosciences raised GBP 1.3 million in a private funding round led by Northstar Ventures.
  • Durham University spinout operates as a contract research organization focused on drug discovery for ageing, longevity, neurodegenerative diseases.
  • Proceeds to scale VivoScan, an in vivo high-throughput screening platform using C. elegans with imaging, machine learning, automation, robotics.
  • Funding to expand commercial work with global pharmaceutical companies, add equipment, recruit staff.
  • Round also included Maven-managed regional funds, the Finance Durham Fund, new angel investors, unlocking a GBP 217,000 Innovate UK grant.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Northstar Ventures Ltd published the original content used to generate this news brief on September 15, 2026, and is solely responsible for the information contained therein.